Načítá se...
Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets
ABSTRACT: Helicobacter pylori, a member of Epsilonproteobacteria, is a Gram-negative microaerophilic bacterium that colonizes gastric mucosa of about 50% of the human population. Although most infections caused by H. pylori are asymptomatic, the microorganism is strongly associated with serious dise...
Uloženo v:
| Vydáno v: | Appl Microbiol Biotechnol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7666284/ https://ncbi.nlm.nih.gov/pubmed/33052519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00253-020-10945-w |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|